Skip to content

Stool Collection Sub-Study of Exact Sciences Protocol 2018-01

Stool Collection Sub-Study of Exact Sciences Protocol 2018-01: Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04473625
Enrollment
291
Registered
2020-07-16
Start date
2020-07-21
Completion date
2022-05-25
Last updated
2022-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colo-rectal Cancer, Cancer

Keywords

Colorectal Cancer, Cologuard, Sample Collection

Brief summary

The primary objective of this sub-study is to obtain de-identified, clinically characterized, stool specimens from subjects with untreated solid tumors for research use in the development and validation of a stool-based test for colorectal cancer.

Interventions

Subjects participating in the study will provide a stool sample within 30 days of enrollment.

Sponsors

Exact Sciences Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is currently enrolled in Exact Sciences Protocol 2018-01. * Subject is willing and able to provide a stool sample. * Subject understands the study procedures and is able to provide written informed consent to participate in the study.

Exclusion criteria

* Subject has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the sub-study protocol, or put the person at undue risk.

Design outcomes

Primary

MeasureTime frameDescription
Stool-based test for colorectal cancerPoint in time (one day) stool collection within 30 days of enrollmentResearch for the development and validation of a stool-based test for colorectal cancer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026